Sun L, Wu S, Coleman K, Fields K C, Humphrey L E, Brattain M G
Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699-0008.
Exp Cell Res. 1994 Sep;214(1):215-24. doi: 10.1006/excr.1994.1251.
Although a great deal is known about the cellular effects of exogenous transforming growth factor-beta (TGF-beta) treatment and the effects of various exogenous agents (including TGF-beta's themselves) on TGF-beta expression, studies of cellular controls for autocrine TGF-beta expression and function have been rare. Since exogenous TGF-beta treatment blocks progression through the cell cycle, it seemed likely that autocrine TGF-beta activity would be induced by growth states in which there was little or no cell division such as confluency or quiescence. Specific TGF-beta 1 or beta 2 neutralizing antibody treatment of a colon carcinoma cell line designated CBS showed that autocrine TGF-beta activity could be demonstrated in quiescent cells but not in preconfluent cells. Studies of kinetics of TGF-beta 1 and beta 2 mRNA levels during the establishment of quiescence revealed a significant increase of both isoforms in quiescent cells. The quiescent cells also secreted three- to fourfold and four-to fivefold higher levels of total (latent plus active) TGF-beta 1 and beta 2 protein in the conditioned media than the confluent cells and preconfluent cells, respectively. There was no detectable active form of either TGF-beta isoform in the conditioned media of preconfluent cells, whereas a significant amount of active TGF-beta 1 and beta 2 was detected in the conditioned media of quiescent cells. Quantitative RNase protection assays were developed to compare the effects of cell crowding vs quiescence on TGF-beta expression. TGF-beta 1 was primarily induced by quiescence. TGF-beta 2 was induced by both quiescence and cell crowding. Increased TGF-beta 1 mRNA levels appeared to be exclusively due to an increase in stability, while increased TGF-beta 2 mRNA levels were due to increased transcription. This growth state-related induction of TGF-beta's was also observed in two other colon carcinoma cell lines. These studies show that TGF-beta 1 and beta 2 are autocrine-negative factors which can be situationally expressed by cells as a function of their growth state. Autocrine expression of the TGF-beta's in this model system appears not to affect exponentially growing cells, but rather to function by maintaining a quiescent state and/or by blocking progression through the cell cycle.
尽管对外源性转化生长因子-β(TGF-β)处理的细胞效应以及各种外源性因子(包括TGF-β自身)对TGF-β表达的影响已有大量了解,但关于自分泌TGF-β表达和功能的细胞调控研究却很少见。由于外源性TGF-β处理会阻断细胞周期进程,因此似乎自分泌TGF-β活性可能由几乎没有或没有细胞分裂的生长状态诱导,如汇合或静止状态。用特异性TGF-β1或β2中和抗体处理一种名为CBS的结肠癌细胞系表明,自分泌TGF-β活性在静止细胞中可以得到证实,但在汇合前细胞中则不然。对静止建立过程中TGF-β1和β2 mRNA水平动力学的研究表明,两种亚型在静止细胞中均显著增加。与汇合细胞和汇合前细胞相比,静止细胞在条件培养基中分泌的总(潜伏加活性)TGF-β1和β2蛋白水平分别高出三到四倍和四到五倍。在汇合前细胞的条件培养基中未检测到任何一种TGF-β亚型的活性形式,而在静止细胞的条件培养基中检测到大量活性TGF-β1和β2。开发了定量核糖核酸酶保护分析来比较细胞拥挤与静止对TGF-β表达的影响。TGF-β1主要由静止诱导。TGF-β2由静止和细胞拥挤共同诱导。TGF-β1 mRNA水平的升高似乎完全是由于稳定性增加,而TGF-β2 mRNA水平的升高则是由于转录增加。在另外两种结肠癌细胞系中也观察到了这种与生长状态相关的TGF-β诱导。这些研究表明,TGF-β1和β2是自分泌负因子,细胞可根据其生长状态在特定情况下表达。在该模型系统中,TGF-β的自分泌表达似乎不影响指数生长的细胞,而是通过维持静止状态和/或阻断细胞周期进程来发挥作用。